Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    July 2021
  1. YANG P, Bocobo GA, Yu PB
    Sotatercept for Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;385:92-93.
    PubMed    


    May 2021
  2. RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
    Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
    N Engl J Med. 2021;384:e89.
    PubMed    


  3. NATHAN SD, Waxman A, Tapson V
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension. Reply.
    N Engl J Med. 2021;384:1871-1872.
    PubMed    


  4. AVDEEV S, Tsareva N, Nekludova G
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1871.
    PubMed    


  5. MORAN-MENDOZA O, Min B, Neder JA
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1870-1871.
    PubMed    


  6. SAGGAR R, Abtin F, Channick R
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1870.
    PubMed    


  7. SOTO FJ, Kravitz JN, Dhand R
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1869-1870.
    PubMed    


  8. NASSER M, Kolb M, Cottin V
    Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
    N Engl J Med. 2021;384:1869.
    PubMed    


    April 2021
  9. NEWMAN JH
    Molecular Rescue in Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;384:1271-1272.
    PubMed    


  10. HUMBERT M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, et al
    Sotatercept for the Treatment of Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;384:1204-1215.
    PubMed     Abstract available


    January 2021
  11. WAXMAN A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, et al
    Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2008470.
    PubMed     Abstract available


  12. TAICHMAN DB
    Optimism for Interstitial Lung Disease-Associated Pulmonary Hypertension?
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMe2033181.
    PubMed    


  13. RUDDER M, Russo M, Ventetuolo CE
    Breathing for Two.
    N Engl J Med. 2021;384:61-68.
    PubMed    


    February 2020
  14. ANDRIST E
    Is He OK?
    N Engl J Med. 2020;382:795-797.
    PubMed    


  15. D'SILVA K, Cockrill B, Anderson WJ, Miller AL, et al
    A Rapid Change in Pressure.
    N Engl J Med. 2020;382:563-570.
    PubMed    


    January 2020
  16. D'SILVA K, Vaidya A, Smithy JW, Anderson WJ, et al
    A Rapid Change in Pressure.
    N Engl J Med. 2020;382:e8.
    PubMed    


    August 2018
  17. BOHULA EA, Wiviott SD, McGuire DK, Inzucchi SE, et al
    Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
    N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1808721.
    PubMed     Abstract available


    December 2015
  18. SITBON O, Channick R, Chin KM, Frey A, et al
    Selexipag for the Treatment of Pulmonary Arterial Hypertension.
    N Engl J Med. 2015;373:2522-33.
    PubMed     Abstract available


    November 2015
  19. ADIGOPULA S, Nsair A
    Images in Clinical Medicine. Left Main Coronary Artery Stent Migration.
    N Engl J Med. 2015;373:1957.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: